Navigation Links
Wildlife Conservation Society to expand health surveillance through PREDICT
Date:10/23/2009

rse of Columbia University Mailman School of Public Health as Director of PREDICT. Morse said that, historically, pandemics occurred perhaps every 30 to 40 years. "But in our modern world, the chances of novel diseases or even a new pandemic emerging are higher than ever, because of how we live and the extent to which we travel. Our human settlements and roadways push deeper into forests and wild areas where we now raise livestock and poultry; and we transport ourselves, our animals and our food farther and faster around the globe."

The PREDICT team will be active in global hotspots where important wildlife host species have significant interaction with domestic animals and high-density human populations. They may include South America's Amazon Basin, Africa's Congo Basin and neighboring Rift Valley, South Asia's Gangetic Plain, and Southeast Asia. Those conditions enable the spread of microbes, especially viruses and bacteria, from animals to humans.

Among the 1,461 pathogens recognized to cause diseases in humans, at least 60 percent are of animal origin. Notable outbreaks of these animal-to-human diseases, or zoonoses (pronounced ZO-oh-NO-sees), include:

  • The 1918 influenza pandemic, which was probably caused by a virus that jumped from birds, killed over 50 million people globally;
  • The human immunodeficiency virus (HIV), which moved from chimpanzees to people, and now infects more than 33 million individuals;
  • Severe acute respiratory syndrome (SARS), which emerged in 2003 from southern China "wet markets" where live wild animals are sold for food; and
  • The recent outbreaks of avian influenza H5N1, or "bird flu."

In a global pandemic today, a quarter of the world's population could be infected and between 51 million and 81 million people could die, with the toll in the United States exceeding 400,000 casualties.


'/>"/>

Contact: John Delaney
jdelaney@wcs.org
718-220-3275
Wildlife Conservation Society
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Protecting humans and animals from diseases in wildlife
2. In search of wildlife-friendly biofuels
3. Strategy outlined for growing bioenergy while protecting wildlife
4. CU-Boulder team identifies DNA "barcodes to help track illegal trading of wildlife products
5. Oil and wildlife dont mix in Ecuadors Eden
6. The war against wildlife comes to an end in Southern Europe
7. US-Mexico border wall could threaten wildlife species
8. Wildlife Conservation Society supports worlds first study of egg-laying mammal
9. Wildlife trade threatens public health and ecosystems
10. Wildlife biologist named Roger Tory Peterson Medal recipient, speaker
11. Wildlife Conservation Society helps Cameroon create new national park
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, ... ), the leading developer of human interface ... authentication technology, the industry,s first fully hardware ... innovative Match-in-Sensor secure authentication technology is literally ... pattern storage and biometric matching within the ...
(Date:7/8/2015)... SAN DIEGO , July 8, 2015 /PRNewswire/ ... of cell-free molecular diagnostics, today announced the launch ... of the Company,s Precision Cancer Monitoring℠ (PCM) technology ... patients receiving one or a combination of the ... and Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
Breaking Biology News(10 mins):Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... personalized medicine for Parkinson,s disease, by investigating signs of ... cells respond to drug treatments. The study was funded ... collected skin cells from patients with genetically inherited forms ... They found that neurons derived from individuals with distinct ...
... is the way to go, if you are a primate ... orangutans, researchers have measured the energy required to navigate a ... up in the trees. Their work was presented at the ... July 2012. The findings help us to understand ...
... Laboratory of Neuro Imaging (LONI) has been responsible for ... generated by the Alzheimer,s Disease Neuroimaging Initiative (ADNI), an ... of Alzheimer,s disease. That stream of ... partners with an ambitious publicprivate effort to dig deeper ...
Cached Biology News:Patient-derived stem cells could improve drug research for Parkinson's 2Patient-derived stem cells could improve drug research for Parkinson's 3Patient-derived stem cells could improve drug research for Parkinson's 4Revolutionary project will obtain entire genome sequences in fight against Alzheimer's 2Revolutionary project will obtain entire genome sequences in fight against Alzheimer's 3
(Date:7/24/2015)...  Champions Oncology (OTC-BB: CSBR), a company engaged in ... personalize the development and use of oncology drugs, today ... for the fourth quarter and fiscal year quarter ended ... market open. The company will host a ... 9:00 a.m. EDT (6:00 a.m. PDT). To participate in ...
(Date:7/24/2015)... China , July 24, 2015 ... manufacturing platform , Expands product offering for chronic ... unmet medical needs in diabetes-related complications and dermatology ... 3SBio Inc., (HKEX:1530) ("3SBio" or ,the Company"), a leading ... researching, developing, manufacturing and marketing biopharmaceutical products, today announced ...
(Date:7/23/2015)... ... July 23, 2015 , ... Science and technology continue to improve all aspects ... devices – according to Susan Chang, MD, director of the Division of Neuro-oncology at ... new technology are impacting the development of new treatments and advancing strategies to minimize ...
(Date:7/23/2015)... (PRWEB) , ... July 23, 2015 , ... The Pittcon ... the Harry S. Mosher Professor of Chemistry and Professor, by courtesy, of Applied Physics ... Optical Single-Molecule Detection in Solids Led to Super-Resolution Nanoscopy in Cells and Beyond” , ...
Breaking Biology Technology:Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 23SBio Acquires Zhejiang Wansheng Pharmaceutical 23SBio Acquires Zhejiang Wansheng Pharmaceutical 33SBio Acquires Zhejiang Wansheng Pharmaceutical 4Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 2Experts Present How Science and New Technology are Driving New Brain Tumor Treatments and Improving Quality of Life 3The 2014 Nobel Prize in Chemistry Recipient W. E. Moerner, to Deliver Wallace H. Coulter Lecture at Pittcon 2016 2The 2014 Nobel Prize in Chemistry Recipient W. E. Moerner, to Deliver Wallace H. Coulter Lecture at Pittcon 2016 3
... , KNOXVILLE, Tenn., Sept. 16 Marking ... colon cancer, EDP Biotech Corporation (EDP), ... today that its ColoMarker(TM) assay achieved 100 percent detection rate ... pre-clinical trials. ColoMarker is the first assay of its kind ...
... SAN DIEGO, Sept. 16 Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: ... new class of small molecule compounds based on endogenous adrenal steroid ... Stock Market on September 15, 2009. , , ... Marketplace Rule 4450(a)(5) (the "Minimum Bid Price Rule") because its common ...
... Collaboration with Biomodels facilitates development of novel drug product , ... Inc., a biotechnology company developing oral antibodies for disease targets accessible ... a Phase I SBIR grant from the National Institute of Dental ... therapeutic for oral mucositis. , , Avaxia is ...
Cached Biology Technology:New Assay Detects 100 Percent of Stage I, II and III Colon Cancers in Pre-Clinical Trials 2New Assay Detects 100 Percent of Stage I, II and III Colon Cancers in Pre-Clinical Trials 3Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 2Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 3Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 2Avaxia Biologics Awarded Phase I SBIR Grant to Develop Antibody Therapeutic for Oral Mucositis 3
One-step, microplate or cuvet, turbidometric, linear detection range 0.096 mg/dL to 11.5 mg/dL. Procedure: 5 min....
Homo sapiens 4-aminobutyrate aminotransferase Antigen: Recombinant Protein...
Request Info...
...
Biology Products: